×

Epilepsy cure in marijuana

1:23 PM ET Mon, 27 June 2016

Justin Gover, GW Pharmaceuticals CEO, speaks with CNBC's Meg Tirrell, about the status of regulatory filings for the Dravet syndrome drug Epidiolex and the coming launch for the medication in U.S. as well as Europe.